Literature DB >> 22013282

Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators.

Raymond J Bergeron1, Shailendra Singh, Neelam Bharti, Yi Jiang.   

Abstract

Iron chelators have been shown to control the growth of cancer cells in culture by sequestering exogenous iron in the media. Thus, the ligands prevent cellular access to the metal. However, because transferrin provides iron to tumor cells in animals, chelators have not been effective antitumor agents. Polyamine chelator conjugates in which the polyamine vectored ligands into cells were far more active than the free chelators themselves. However, the free ligands were not released from the vector once in the cell. The current study focuses on the synthesis and preliminary evaluation of a polyamine chelator conjugate capable of releasing the free ligand intracellularly via a nonspecific esterase.

Entities:  

Year:  2010        PMID: 22013282      PMCID: PMC3195516          DOI: 10.1055/s-0030-1258245

Source DB:  PubMed          Journal:  Synthesis (Stuttg)        ISSN: 0039-7881            Impact factor:   3.157


  31 in total

1.  Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives.

Authors:  R J Bergeron; R Müller; G Huang; J S McManis; S E Algee; H Yao; W R Weimar; J Wiegand
Journal:  J Med Chem       Date:  2001-07-19       Impact factor: 7.446

2.  Combined regulation of ornithine and S-adenosylmethionine decarboxylases by spermine and the spermine analogue N1 N12-bis(ethyl)spermine.

Authors:  C W Porter; A E Pegg; B Ganis; R Madhabala; R J Bergeron
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

3.  Effects of the Vibrio cholerae siderophore vibriobactin on the growth characteristics of L1210 cells.

Authors:  R J Bergeron; R Braylan; S Goldey; M Ingeno
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

4.  Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.

Authors:  R J Bernacki; R J Bergeron; C W Porter
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

5.  Synthetic polyamine analogues as antineoplastics.

Authors:  R J Bergeron; A H Neims; J S McManis; T R Hawthorne; J R Vinson; R Bortell; M J Ingeno
Journal:  J Med Chem       Date:  1988-06       Impact factor: 7.446

6.  Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells.

Authors:  R J Bergeron; T R Hawthorne; J R Vinson; D E Beck; M J Ingeno
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

7.  Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.

Authors:  J B Porter; M Gyparaki; L C Burke; E R Huehns; P Sarpong; V Saez; R C Hider
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

Review 8.  Development of polyamine analogs as cancer therapeutic agents.

Authors:  Thresia Thomas; Srivani Balabhadrapathruni; Michael A Gallo; T J Thomas
Journal:  Oncol Res       Date:  2002       Impact factor: 5.574

9.  Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity.

Authors:  P R Libby; R J Bergeron; C W Porter
Journal:  Biochem Pharmacol       Date:  1989-05-01       Impact factor: 5.858

Review 10.  Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators.

Authors:  C Hershko
Journal:  Baillieres Clin Haematol       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.